Actively Recruiting
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy
Led by University Hospital, Bordeaux · Updated on 2025-12-16
200
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aim of the study is to develop a diagnostic proteomic profile of cholangiocarcinoma using bile samples. The primary endpoint will be the rate of concordant positive diagnoses obtained from bile samples based on proteomic profiling compared with histological reference diagnoses (concomitant cytological sampling and/or final histological sampling).
CONDITIONS
Official Title
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 18 years and older
- Patients with bile duct stenosis who require endoscopy with retrograde papillary catheterization or a radiological procedure for diagnostic purposes (histological samples) as part of their management
- Oral consent
You will not qualify if you...
- Pregnant woman
- Patient under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Bordeaux
Pessac, France
Actively Recruiting
Research Team
A
Arthur Marichez, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here